MedPath
HSA Approval

NEVOPRES TABLET 5MG

SIN15958P

NEVOPRES TABLET 5MG

NEVOPRES TABLET 5MG

June 16, 2020

GLORIOUS DEXA SINGAPORE PTE. LTD.

GLORIOUS DEXA SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGLORIOUS DEXA SINGAPORE PTE. LTD.
Licence HolderGLORIOUS DEXA SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C07AB12

nebivolol

Manufacturer Information

GLORIOUS DEXA SINGAPORE PTE. LTD.

PT. Dexa Medica

Active Ingredients

Nebivolol Hydrochloride 5.45mg eqv Nebivolol

5mg

Nebivolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEVOPRES TABLET 5MG - HSA Approval | MedPath